The Leukemia Therapeutics market is witnessing significant advancements propelled by novel treatment modalities, reshaping the industry landscape. As precision medicine gains momentum, the market is evolving with increasing adoption of targeted therapies and immunotherapies that offer improved patient outcomes. Emerging regulatory approvals and increased R&D investments are also key...